Succinylcholine Chloride
Succinylcholine Chloride Injection, USP
Approved
Approval ID
4a63029a-a7c6-43f7-b485-c14ef7a4e92b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 30, 2023
Manufacturers
FDA
Nexus Pharmaceuticals Inc
DUNS: 620714787
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Succinylcholine Chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code14789-104
Application NumberANDA213552
Product Classification
M
Marketing Category
C73584
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 30, 2023
FDA Product Classification
INGREDIENTS (6)
Succinylcholine ChlorideActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB
MethylparabenInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PropylparabenInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT